Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
8,537
datasets available to search
ShareScore release 0.9.0
Dataset results
8,537 results for “Openness”
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
ClinicalTrials.gov study NCT01371721. IPD Sharing: Not stated. Countries: 2. Publications: 1.
An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia
ClinicalTrials.gov study NCT02180724. IPD Sharing: YES. Countries: 7. Publications: 2.
A Phase I, Open-label Study to Assess Bioavailability of a Single Oral Dose of AZD9291 vs an IV Dose of [14C]AZD9291
ClinicalTrials.gov study NCT02491944. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
ClinicalTrials.gov study NCT01772823. IPD Sharing: Not stated. Countries: 1. Publications: 2.
An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
ClinicalTrials.gov study NCT03882918. IPD Sharing: NO. Countries: 2. Publications: 1.
Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy
ClinicalTrials.gov study NCT00160654. IPD Sharing: Not stated. Countries: 6. Publications: 1.
An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults
ClinicalTrials.gov study NCT01753193. IPD Sharing: YES. Countries: 13. Publications: 1.
A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting
ClinicalTrials.gov study NCT01999348. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-Label Placebos to Treat Fatigue in Multiple Sclerosis
ClinicalTrials.gov study NCT04002102. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy and Safety of 0.25% Timolol Gel in Healing Surgical Open Wounds
ClinicalTrials.gov study NCT03452072. IPD Sharing: UNDECIDED. Countries: 1. Publications: 9.
Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen
ClinicalTrials.gov study NCT01856257. IPD Sharing: YES. Countries: 1. Publications: 1.
An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
ClinicalTrials.gov study NCT00337285. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
ClinicalTrials.gov study NCT02178592. IPD Sharing: Not stated. Countries: 7. Publications: 1.
A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma
ClinicalTrials.gov study NCT00866047. IPD Sharing: Not stated. Countries: 5. Publications: 2.
A Randomized Controlled Trial of Open Surgical vs. Minimally-invasive Voluntary Adult Male Circumcision
ClinicalTrials.gov study NCT01688310. IPD Sharing: Not stated. Countries: 1. Publications: 11.
Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
ClinicalTrials.gov study NCT00307684. IPD Sharing: Not stated. Countries: 7. Publications: 2.
Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder
ClinicalTrials.gov study NCT01338818. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease
ClinicalTrials.gov study NCT02023866. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects
ClinicalTrials.gov study NCT02135692. IPD Sharing: YES. Countries: 18. Publications: 1.
An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
ClinicalTrials.gov study NCT02003144. IPD Sharing: Not stated. Countries: 20. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.